XJPX
8938
Market cap20mUSD
Oct 09, Last price
318.00JPY
1D
0.63%
1Q
-9.40%
Jan 2017
-66.17%
IPO
-85.55%
Name
Glome Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
GLOME Holdings, Inc., along with its affiliated entities, operates in diverse medical and real estate sectors, serving markets both within Japan and internationally. The company manages a range of healthcare facilities, including hospitals (such as nursing care hospitals and associated facilities), clinics, and dedicated centers for elderly and general health care. Beyond direct medical services, it furnishes information related to healthcare, medical services, and welfare, and also provides gold loans. GLOME Holdings also offers services in personnel and administrative training, economic management, operational guidance, and informed career placement assistance. Its support functions extend to aid with medicine and medical equipment procurement, inventory control, food service management, information technology, real estate facility administration, the creation of personnel systems, and regulatory formulation. Furthermore, the company advises and guides various business undertakings, including medical corporations, and engages in the leasing of commercial properties. Founded in 1987 and headquartered in Tokyo, Japan, the company adopted its current name, GLOME Holdings, Inc., in October 2019, having previously been known as LC Holdings, Inc.
Key people
Shuzo Orihashi
Chairman of the Board, Representative Director · since 2025
Masazumi Sugawara
President, Co-Chief Executive Officer, President of Subsidiaries, Representative Director · since 2025
Qing He
Managing Director, President and Chairman of Subsidiaries · since 2025
Yoshihide Mori
President of Subsidiary, Director · since 2023
Debiao Chen
Representative Director · since 2025
Tatsuyuki Douno
Independent Director · since 2022
Emiko Manabe
Independent Director · since 2022
Liyun Zhang
Independent Director · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||